TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4( )CD25 ( ) Treg apoptosis (Q39246438)

10 September 2017

title

TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4( )CD25 ( ) Treg apoptosis (English)

1 reference

10 September 2017

Zhijuan Diao

1

1 reference

10 September 2017

Juan Shi

2

1 reference

10 September 2017

Jieqing Zhu

3

1 reference

10 September 2017

Haiqin Yuan

4

1 reference

10 September 2017

Qiang Ru

5

1 reference

10 September 2017

Shilian Liu

6

1 reference

10 September 2017

Yanxin Liu

7

1 reference

10 September 2017

Dexian Zheng

8

1 reference

10 September 2017

publication date

11 November 2012

1 reference

Cancer Immunology, Immunotherapy

10 September 2017

published in

1 reference

10 September 2017

volume

62

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

653-663

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

TRAIL-R as a negative regulator of innate immune cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4 T cells is IL-10-dependent and reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

CD4( ) CD25( ) FoxP3( ) regulatory T cells suppress cytotoxicity of CD8( ) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

NK cells and Treg cells: a fascinating dance cheek to cheek

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Intraepithelial CD8 tumor-infiltrating lymphocytes and a high CD8 /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 CD25 CD4 regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Toll-like receptor 8-mediated reversal of CD4 regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Denileukin diftitox: a novel immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

In contrast to effector T cells, CD4 CD25 FoxP3 regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Depleting intratumoral CD4 CD25 regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4 CD25 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

The tumor-draining lymph node as an immune-privileged site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

Enhanced functionality of CD4 CD25(high)FoxP3 regulatory T cells in the peripheral blood of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-012-1370-X

10.1007/S00262-012-1370-X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference